Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Olympic Selection Trials: Ashi-Swapnil Shine In 3-Position Shooting -
Mirzapur 3 OTT Release Date, Platform: When Will Mirzapur Season 3 Premiere On Amazon Prime Video? -
25% Dividend Record Date: Logistic Stock Nears 1-Year High And It Belongs To Mahindra; Motilal Neutral -
Telangana Inter Manabadi 1st and 2nd Year Results 2024 to be Declared Tomorrow -
Chrysler Pacifica Marks Seven Years As Most Awarded Minivan With New Campaign -
Anant Ambani-Radhika Merchant's Wedding Function Details Are Out, Check out Ambani Bahu-To-Be's Chic Fashion! -
Xiaomi Robot Vacuum Cleaner S10, Handheld Garment Steamer, and Redmi Buds 5A Launched in India -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Sun Pharma commercially launches Amifostine
New Delhi, Mar 31 (UNI) Sun Pharmaceutical Industries Ltd today said it has commercially launched generic Amifostine for Injection 500mg, which is therapeutically equivalent to Medlmmune's Ethyol.
The company's product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories, said a statement.
The firm had received a USFDA approval for this earlier in March 2008.
Ethyoi has annual sales of approximately 80 million dollars in the US.
Sun Pharma, being the first-to-file an ANDA for generic Ethyol, has a 180-day marketing exclusivity.
UNI
PBB
SR
DS1145
Comments
Story first published: Monday, March 31, 2008, 12:06 [IST]
